DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Charles ED, Neuschwander-Tetri BA, Frias JP. et al.
Pegbelfermin (BMS-98036)PEGylated FGF21, in patients with obesity and type 2
diabetes: results from a randomized phase 2 study.
Obesity 2019;
27: 41-49
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.